Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/1805
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorSHIOZAKI, Afonso Akio-
dc.contributor.authorSENRA, Tiago-
dc.contributor.authorARTEAGA, Edmund-
dc.contributor.authorMARTINELLI FILHO, Martino-
dc.contributor.authorPITA, Cristiane Guedes-
dc.contributor.authorAVILA, Luis Francisco R.-
dc.contributor.authorPARGA FILHO, Jose Rodrigues-
dc.contributor.authorMADY, Charles-
dc.contributor.authorKALIL-FILHO, Roberto-
dc.contributor.authorBLUEMKE, David A.-
dc.contributor.authorROCHITTE, Carlos Eduardo-
dc.date.accessioned2013-09-23T16:36:32Z-
dc.date.available2013-09-23T16:36:32Z-
dc.date.issued2013-
dc.identifier.citationJOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY, v.7, n.3, p.173-181, 2013-
dc.identifier.issn1934-5925-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/1805-
dc.description.abstractBackground: Myocardial fibrosis (MF) occurs in up to 80% of subjects with asymptomatic or mildly symptomatic hypertrophic cardiomyopathy (HCM) and can constitute an arrhythmogenic substrate for re-entrant, life-threatening ventricular arrhythmias in predisposed persons. Objective: The aim was to investigate whether MF detected by delayed enhancement cardiac CT is predictive of ventricular tachycardia (VT) and fibrillation (VF) that require appropriate therapy by an implantable cardioverter defibrillator (ICD) in patients with HCM. Methods: Twenty-six patients with HCM with previously (for at least 1 year) implanted ICD underwent MF evaluation by cardiac CT. MF was quantified by myocardial delayed enhanced cardiac CT. Data on ICD firing were recorded every 3 months after ICD implantation. Risk factors for sudden cardiac death in patients with HCM were evaluated in all patients. Results: MF was present in 25 of 26 patients (96%) with mean fibrosis mass of 20.5 +/- 15.8 g. Patients with appropriate ICD shocks for VF/VT had significantly greater MF mass than patients without (29.10 +/- 19.13 g vs 13.57 +/- 8.31 g; P = .01). For a MF mass of at least 18 g, sensitivity and specificity for appropriate ICD firing were 73% (95% CI, 49%-88%) and 71% (95% CI, 56%-81%), respectively. Kaplan-Meier curves indicated a significantly greater VF/VT event rate in patients with MF mass >= 18 g than in patients with MF <18 g (P = .02). In the Cox regression analysis, the amount of MF was independently associated with VF/VT in ICD-stored electrograms. Conclusion: The mass of MF detected by cardiac CT in patients with HCM at high risk of sudden death was associated with appropriate ICD firings.-
dc.description.sponsorshipFAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [07/58876-8]-
dc.description.sponsorshipZerbini Foundation-
dc.description.sponsorshipBrazilian Society of Cardiology (Sociedade Brasileira de Cardiologia)-
dc.language.isoeng-
dc.publisherELSEVIER SCIENCE INC-
dc.relation.ispartofJournal of Cardiovascular Computed Tomography-
dc.rightsrestrictedAccess-
dc.subjectHypertrophic cardiomyopathy-
dc.subjectMyocardial fibrosis-
dc.subjectVentricular arrhythmias-
dc.subjectDelayed enhancement cardiac computed tomography-
dc.subjectImplantable cardiac defibrillator-
dc.subject.othercardiovascular magnetic-resonance-
dc.subject.otherlate gadolinium enhancement-
dc.subject.otherbinding protein-c-
dc.subject.otherimplantable cardioverter-defibrillators-
dc.subject.othermultidetector computed-tomography-
dc.subject.othercoronary-artery-disease-
dc.subject.othersudden-death-
dc.subject.otherdelayed enhancement-
dc.subject.otherprognostic-significance-
dc.subject.otheralpha-tropomyosin-
dc.titleMyocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients with hypertrophic cardiomyopathy-
dc.typearticle-
dc.rights.holderCopyright ELSEVIER SCIENCE INC-
dc.identifier.doi10.1016/j.jcct.2013.04.002-
dc.identifier.pmid23849490-
dc.subject.wosCardiac & Cardiovascular Systems-
dc.subject.wosRadiology, Nuclear Medicine & Medical Imaging-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.author.externalSHIOZAKI, Afonso Akio:Univ Sao Paulo, Sch Med, Heart Inst InCor, Cardiovasc Magnet Resonance & Computed Tomog Sect, Sao Paulo, Brazil-
hcfmusp.author.externalSENRA, Tiago:Univ Sao Paulo, Sch Med, Heart Inst InCor, Cardiovasc Magnet Resonance & Computed Tomog Sect, Sao Paulo, Brazil-
hcfmusp.author.externalPITA, Cristiane Guedes:Univ Sao Paulo, Sch Med, Heart Inst InCor, Pacemaker Clin, Sao Paulo, Brazil-
hcfmusp.author.externalBLUEMKE, David A.:NIH, Ctr Clin, Bethesda, MD 20892 USA-
hcfmusp.description.beginpage173-
hcfmusp.description.endpage181-
hcfmusp.description.issue3-
hcfmusp.description.volume7-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84880148904-
hcfmusp.origem.idWOS:000322097900005-
hcfmusp.publisher.cityNEW YORK-
hcfmusp.publisher.countryUSA-
hcfmusp.relation.referenceAdabag AS, 2008, J AM COLL CARDIOL, V51, P1369, DOI 10.1016/j.jacc.2007.11.071-
hcfmusp.relation.referenceAlexandre J, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-12-
hcfmusp.relation.referenceANAN R, 1994, J CLIN INVEST, V93, P280, DOI 10.1172/JCI116957-
hcfmusp.relation.referenceBello D, 2005, J AM COLL CARDIOL, V45, P1104, DOI 10.1016/j.jacc.2004.12.057-
hcfmusp.relation.referenceBerliner JI, 2013, INT J CARDIOVAS IMAG, V29, P191, DOI 10.1007/s10554-012-0048-y-
hcfmusp.relation.referenceBruder O, 2010, J AM COLL CARDIOL, V56, P875, DOI 10.1016/j.jacc.2010.05.007-
hcfmusp.relation.referenceCECCHI F, 1995, J AM COLL CARDIOL, V26, P1529, DOI 10.1016/0735-1097(95)00353-3-
hcfmusp.relation.referenceCECCHI F, 1989, J AM COLL CARDIOL, V13, P1283-
hcfmusp.relation.referenceCharron P, 1998, CIRCULATION, V97, P2230-
hcfmusp.relation.referenceChoudhury L, 2002, J AM COLL CARDIOL, V40, P2156, DOI 10.1016/S0735-1097(02)02602-5-
hcfmusp.relation.referenceDimitrow PP, 2008, INT J CARDIOVAS IMAG, V24, P77, DOI 10.1007/s10554-007-9209-9-
hcfmusp.relation.referenceElliott P, 2004, LANCET, V363, P1881, DOI 10.1016/S0140-6736(04)16358-7-
hcfmusp.relation.referenceElliott PM, 2001, LANCET, V357, P420, DOI 10.1016/S0140-6736(00)04005-8-
hcfmusp.relation.referenceElliott PM, 2000, J AM COLL CARDIOL, V36, P2212, DOI 10.1016/S0735-1097(00)01003-2-
hcfmusp.relation.referenceFord WR, 1997, CAN J PHYSIOL PHARM, V75, P1075, DOI 10.1139/cjpp-75-9-1075-
hcfmusp.relation.referenceGerber BL, 2006, CIRCULATION, V113, P823, DOI 10.1161/CIRCULATIONAHA.104.529511-
hcfmusp.relation.referenceGersh BJ, 2011, J AM COLL CARDIOL, V58, pE212, DOI 10.1016/j.jacc.2011.06.011-
hcfmusp.relation.referenceIles L, 2011, J AM COLL CARDIOL, V57, P821, DOI 10.1016/j.jacc.2010.06.062-
hcfmusp.relation.referenceKanal E, 2004, AM J ROENTGENOL, V182, P1111-
hcfmusp.relation.referenceKwong RY, 2006, CIRCULATION, V113, P2733, DOI 10.1161/CIRCULATIONHA.105.570648-
hcfmusp.relation.referenceLardo AC, 2006, CIRCULATION, V113, P394, DOI 10.1161/CIRCULATIONAHA.105.521450-
hcfmusp.relation.referenceMaron Barry J., 2003, Journal of the American College of Cardiology, V42, P1687, DOI 10.1016/S0735-1097(03)00941-0-
hcfmusp.relation.referenceMaron BJ, 2001, J AM COLL CARDIOL, V38, P315, DOI 10.1016/S0735-1097(01)01386-9-
hcfmusp.relation.referenceMaron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199-
hcfmusp.relation.referenceMaron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308-
hcfmusp.relation.referenceMaron BJ, 2000, NEW ENGL J MED, V342, P365, DOI 10.1056/NEJM200002103420601-
hcfmusp.relation.referenceMARON BJ, 1982, CIRCULATION, V65, P1388-
hcfmusp.relation.referenceMaron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783-
hcfmusp.relation.referenceMaron BJ, 1997, LANCET, V350, P127, DOI 10.1016/S0140-6736(97)01282-8-
hcfmusp.relation.referenceMARON BJ, 1981, AM J CARDIOL, V48, P252, DOI 10.1016/0002-9149(81)90604-4-
hcfmusp.relation.referenceMCKENNA W, 1981, AM J CARDIOL, V47, P532, DOI 10.1016/0002-9149(81)90535-X-
hcfmusp.relation.referenceMCKENNA WJ, 1981, BRIT HEART J, V46, P168-
hcfmusp.relation.referenceMonserrat L, 2003, J AM COLL CARDIOL, V42, P873, DOI 10.1016/S0735-1097(03)00827-1-
hcfmusp.relation.referenceMoon JCC, 2004, J AM COLL CARDIOL, V43, P2260, DOI 10.1016/j.jacc.2004.03.035-
hcfmusp.relation.referenceMoon JCC, 2003, J AM COLL CARDIOL, V41, P1561, DOI 10.1016/S0735-1097(03)00189-X-
hcfmusp.relation.referenceNazarian S, 2011, ANN INTERN MED, V155, P415, DOI 10.7326/0003-4819-155-7-201110040-00004-
hcfmusp.relation.referenceNiimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802-
hcfmusp.relation.referenceNoureldin RA, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-17-
hcfmusp.relation.referenceO'Hanlon R, 2010, J AM COLL CARDIOL, V56, P867, DOI 10.1016/j.jacc.2010.05.010-
hcfmusp.relation.referenceRochitte Carlos Eduardo, 2006, Curr Cardiol Rep, V8, P44, DOI 10.1007/s11886-006-0010-5-
hcfmusp.relation.referenceRubinshtein R, 2010, CIRC-HEART FAIL, V3, P51, DOI 10.1161/CIRCHEARTFAILURE.109.854026-
hcfmusp.relation.referenceSadoul N, 1997, CIRCULATION, V96, P2987-
hcfmusp.relation.referenceShiozaki AA, 2010, ARQ BRAS CARDIOL, V94, P535, DOI 10.1590/S0066-782X2010005000017-
hcfmusp.relation.referenceShiozaki AA, 2007, CIRCULATION, V115, pE430, DOI 10.1161/CIRCULATIONAHA.106.674911-
hcfmusp.relation.referenceShiozaki AA, 2007, ARQ BRAS CARDIOL, V88, P243, DOI 10.1590/S0066-782X2007000200018-
hcfmusp.relation.referenceShirani J, 2000, J AM COLL CARDIOL, V35, P36, DOI 10.1016/S0735-1097(99)00492-1-
hcfmusp.relation.referenceSPIRITO P, 1990, J AM COLL CARDIOL, V15, P1521-
hcfmusp.relation.referenceSPIRITO P, 1994, CIRCULATION, V90, P2743-
hcfmusp.relation.referenceSpirito P, 2000, NEW ENGL J MED, V342, P1778, DOI 10.1056/NEJM200006153422403-
hcfmusp.relation.referenceSpirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107-
hcfmusp.relation.referenceTANAKA M, 1986, BRIT HEART J, V55, P575-
hcfmusp.relation.referenceTeraoka K, 2004, MAGN RESON IMAGING, V22, P155, DOI 10.1016/j.mri.2003.08.009-
hcfmusp.relation.referenceTHIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X-
hcfmusp.relation.referenceVogel-Claussen J, 2006, RADIOGRAPHICS, V26, P795, DOI 10.1148/rg.263055047-
hcfmusp.relation.referenceWATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603-
hcfmusp.relation.referenceWu KC, 2008, J AM COLL CARDIOL, V51, P2414, DOI 10.1016/j.jacc.2008.03.018-
hcfmusp.relation.referenceYen AT, 2006, CIRCULATION, V114, P32-
dc.description.indexMEDLINE-
hcfmusp.remissive.sponsorshipFAPESP-
hcfmusp.remissive.sponsorshipFund Zerbini-
hcfmusp.citation.scopus46-
hcfmusp.scopus.lastupdate2022-05-06-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCP
Departamento de Cardio-Pneumologia - FM/MCP

Artigos e Materiais de Revistas Científicas - HC/InCor
Instituto do Coração - HC/InCor

Artigos e Materiais de Revistas Científicas - LIM/11
LIM/11 - Laboratório de Cirurgia Cardiovascular e Fisiopatologia da Circulação


Files in This Item:
File Description SizeFormat 
art_ARTEAGA_Myocardial_fibrosis_detected_by_cardiac_CT_predicts_ventricular_2013.PDF
  Restricted Access
publishedVersion (English)785.06 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.